Take­da kicks up GPCR work with So­sei Hep­tares, dish­ing out $26M to get GI drug dis­cov­ery go­ing

Take­da is join­ing the grow­ing group of big-league play­ers en­list­ing the GPCR ex­perts at So­sei Hep­tares for drug de­sign work.

Much like the

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.